Overview

A Bioavailability Study of Two Different PEG-rhGH Preparations.

Status:
COMPLETED
Trial end date:
2025-03-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations.
Phase:
PHASE1
Details
Lead Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Treatments:
polyethylene glycol-recombinant human growth hormone